Invesco’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $29.5M | Sell |
|
|||||
|
2025
Q2 | $34M | Buy |
|
|||||
|
2025
Q1 | $35.4M | Sell |
|
|||||
|
2024
Q4 | $33.2M | Sell |
|
|||||
|
2024
Q3 | $38.2M | Buy |
|
|||||
|
2024
Q2 | $44.2M | Buy |
|
|||||
|
2024
Q1 | $36.2M | Buy |
|
|||||
|
2023
Q4 | $38.2M | Sell |
|
|||||
|
2023
Q3 | $39.7M | Sell |
|
|||||
|
2023
Q2 | $85.3M | Sell |
|
|||||
|
2023
Q1 | $177M | Sell |
|
|||||
|
2022
Q4 | $190M | Buy |
|
|||||
|
2022
Q3 | $34.3M | Buy |
|
|||||
|
2022
Q2 | $24.6M | Buy |
|
|||||
|
2022
Q1 | $22.3M | Buy |
|
|||||
|
2021
Q4 | $25M | Sell |
|
|||||
|
2021
Q3 | $22.4M | Buy |
|
|||||
|
2021
Q2 | $23M | Sell |
|
|||||
|
2021
Q1 | $30.6M | Buy |
|
|||||
|
2020
Q4 | $28M | Sell |
|
|||||
|
2020
Q3 | $44.6M | Buy |
|
|||||
|
2020
Q2 | $66.7M | Buy |
|
|||||
|
2020
Q1 | $44.6M | Sell |
|
|||||
|
2019
Q4 | $52.4M | Sell |
|
|||||
|
2019
Q3 | $152M | Sell |
|
|||||
|
2019
Q2 | $244M | Sell |
|
|||||
|
2019
Q1 | $308M | Buy |
|
|||||
|
2018
Q4 | $282M | Buy |
|
|||||
|
2018
Q3 | $320M | Sell |
|
|||||
|
2018
Q2 | $312M | Sell |
|
|||||
|
2018
Q1 | $340M | Sell |
|
|||||
|
2017
Q4 | $402M | Buy |
|
|||||
|
2017
Q3 | $418M | Buy |
|
|||||
|
2017
Q2 | $382M | Buy |
|
|||||
|
2017
Q1 | $319M | Buy |
|
|||||
|
2016
Q4 | $281M | Buy |
|
|||||
|
2016
Q3 | $283M | Buy |
|
|||||
|
2016
Q2 | $183M | Sell |
|
|||||
|
2016
Q1 | $203M | Sell |
|
|||||
|
2015
Q4 | $277M | Buy |
|
|||||
|
2015
Q3 | $260M | Buy |
|
|||||
|
2015
Q2 | $156M | Buy |
|
|||||
|
2015
Q1 | $111M | Buy |
|
|||||
|
2014
Q4 | $80.3M | Buy |
|
|||||
|
2014
Q3 | $36.1M | Sell |
|
|||||
|
2014
Q2 | $31.2M | Sell |
|
|||||
|
2014
Q1 | $84.3M | Sell |
|
|||||
|
2013
Q4 | $132M | Sell |
|
|||||
|
2013
Q3 | $144M | Sell |
|
|||||
|
2013
Q2 | $119M | Buy |
|